| 1 |
34571726 | Vincristine in Combination Therapy of Cancer: Emerging Trends in Clinics. | 2021 Aug 31 |
1 |
| 2 |
22249209 | Association of CD20 levels with clinicopathological parameters and its prognostic significance for patients with DLBCL. | 2012 Jul |
1 |
| 3 |
21842694 | [A case of Sjogren syndrome coexistent with MALT lymphoma occurring along the parotid gland and trachea]. | 2011 Jul |
1 |
| 4 |
20660823 | Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia. | 2010 Aug 20 |
1 |
| 5 |
21084053 | Malignant lymphoma of the kidney mimicking rapid progressive glomerulonephritis. | 2010 Dec |
1 |
| 6 |
19833600 | Monotherapy with anti-CD20 monoclonal antibody in a heart transplant recipient with sick sinus syndrome and posttransplantation lymphoproliferative disorder: a case report. | 2009 Oct |
1 |
| 7 |
18537979 | Recent advances in the understanding and management of diffuse large B-cell lymphoma in children. | 2008 Jul |
1 |
| 8 |
17218490 | Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases. | 2007 Apr |
1 |
| 9 |
15170171 | A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma. | 2004 Jul |
1 |
| 10 |
12902896 | Successful treatment of refractory low grade duodenal lymphoma with rituximab, an anti-CD20 monoclonal antibody. | 2003 Aug |
1 |
| 11 |
10335483 | Cytocidal activity of PBL, LAK, and IDEC-C2B8 and expression of HLA class 1, ICAM-1, and CD20 in vincristine-resistant hematologic cell lines. | 1999 May |
1 |
| 12 |
10444162 | Cost-minimization analysis of CHOP, fludarabine and rituximab for the treatment of relapsed indolent B-cell non-Hodgkin's lymphoma in the U.K. | 1999 Jul |
1 |